Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 3
1980 2
1982 2
1983 3
1984 4
1985 1
1986 3
1987 2
1988 1
1989 2
1990 1
1991 1
1992 2
1993 2
1994 6
1995 5
1996 11
1997 18
1998 14
1999 23
2000 11
2001 8
2002 4
2003 10
2004 10
2005 6
2006 5
2007 5
2008 9
2009 12
2010 10
2011 6
2012 3
2013 3
2014 4
2015 5
2016 2
2017 2
2018 1
2021 1
2022 5
2023 5
2024 4
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Revised equations for estimated GFR from serum creatinine in Japan.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Matsuo S, et al. Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1. Am J Kidney Dis. 2009. PMID: 19339088
Peritoneal damage by peritoneal dialysis solutions.
Ito T, Yorioka N. Ito T, et al. Among authors: yorioka n. Clin Exp Nephrol. 2008 Aug;12(4):243-249. doi: 10.1007/s10157-008-0032-y. Epub 2008 Feb 15. Clin Exp Nephrol. 2008. PMID: 18274701 Review.
Vascular calcification in chronic kidney disease.
Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular Calcification Work Group. Goodman WG, et al. Among authors: yorioka n. Am J Kidney Dis. 2004 Mar;43(3):572-9. doi: 10.1053/j.ajkd.2003.12.005. Am J Kidney Dis. 2004. PMID: 14981617 Review. No abstract available.
Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis.
Tanaka M, Kaji K, Nishimura N, Asada S, Koizumi A, Matsuda T, Yorioka N, Tsuji Y, Fujinaga Y, Sato S, Namisaki T, Akahane T, Yoshiji H. Tanaka M, et al. Among authors: yorioka n. Biochim Biophys Acta Mol Cell Res. 2024 Feb;1871(2):119649. doi: 10.1016/j.bbamcr.2023.119649. Epub 2023 Dec 12. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 38097064
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients.
Murata K, Namisaki T, Fujimoto Y, Takeda S, Enomoto M, Takaya H, Tsuji Y, Shibamoto A, Suzuki J, Kubo T, Iwai S, Tomooka F, Tanaka M, Kaneko M, Asada S, Koizumi A, Yorioka N, Matsuda T, Ozutsumi T, Ishida K, Ogawa H, Takagi H, Fujinaga Y, Furukawa M, Sawada Y, Nishimura N, Kitagawa K, Sato S, Kaji K, Inoue T, Asada K, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Murata K, et al. Among authors: yorioka n. Cancer Diagn Progn. 2022 Mar 3;2(2):184-193. doi: 10.21873/cdp.10093. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399181 Free PMC article.
Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan.
Hanatani JI, Kitagawa K, Tomooka F, Asada S, Mitoro A, Fujinaga Y, Nishimura N, Sato S, Shibamoto A, Fujimoto Y, Kubo T, Iwai S, Tsuji Y, Namisaki T, Akahane T, Kaji K, Tanaka M, Koizumi A, Yorioka N, Matsuda T, Masuda H, Takami M, Kikuchi M, Kawanishi M, Ohoka K, Watanabe D, Kawasaki A, Yoshiji H. Hanatani JI, et al. Among authors: yorioka n. DEN Open. 2024 Apr 30;5(1):e371. doi: 10.1002/deo2.371. eCollection 2025 Apr. DEN Open. 2024. PMID: 38694541 Free PMC article.
Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.
Muso E, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Saito T, Mune M, Sugiyama S, Iino Y, Hirano T, Hattori M, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Oda H, Mori K, Kimura H, Ito O, Nishiyama A, Maruyama S, Inagi R, Fujimoto S, Tsukamoto T, Suzuki Y, Honda H, Babazono T, Tsuruya K, Yuzawa Y. Muso E, et al. Among authors: yorioka n. Ther Apher Dial. 2022 Feb;26(1):220-228. doi: 10.1111/1744-9987.13694. Epub 2021 Jun 21. Ther Apher Dial. 2022. PMID: 34057286 Free PMC article.
220 results